UOTTAIMCU
INDV icon

University of Texas/Texas AM Investment Management Co (UTIMCO)’s Indivior Pharmaceuticals INDV Stock Holding History

University of Texas/Texas AM Investment Management Co (UTIMCO)’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$746K Sell
18,186
-7,199
-28% -$261K 0.09% 104
2026
Q1 		$774K Buy
25,385
+19,034
+300% +$629K 0.11% 100
2025
Q4 		$228K Buy
+6,351
New +$194K 0.03% 149

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

University of Texas/Texas AM Investment Management Co (UTIMCO)'s INDV Position: Q2 2026 in Review

University of Texas/Texas AM Investment Management Co (UTIMCO) reduced its Indivior Pharmaceuticals (INDV) stake by 28% in Q2 2026, selling an estimated $261K and leaving 18,186 shares worth $746K. The position accounts for 0.09% of the portfolio, ranked #104.

University of Texas/Texas AM Investment Management Co (UTIMCO) first reported a position in INDV in Q4 2025 and has held it in 3 quarters since. The position peaked at $774K in Q1 2026. 336 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • University of Texas/Texas AM Investment Management Co (UTIMCO) held 18,186 shares of Indivior Pharmaceuticals worth $746K as of Q2 2026.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) sold 7,199 Indivior Pharmaceuticals shares in Q2 2026, an estimated $261K.
  • Indivior Pharmaceuticals made up 0.09% of University of Texas/Texas AM Investment Management Co (UTIMCO)'s portfolio in Q2 2026, its #104 holding.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) first reported a position in Indivior Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s Indivior Pharmaceuticals position peaked at $774K in Q1 2026.
  • 336 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on University of Texas/Texas AM Investment Management Co (UTIMCO)'s 13F filing for Q2 2026, filed 3 Aug 2026.